What is the current stock price of RenovaCare, Inc. (RCAR)?

As of the latest market data, RenovaCare, Inc. (RCAR) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does RenovaCare, Inc. (RCAR) pay a dividend?

Based on current data, RenovaCare, Inc. does not have a confirmed active dividend policy.

What is the market cap of RenovaCare, Inc.?

The current market capitalization of RenovaCare, Inc. (RCAR) is approximately unavailable.

RCAR

RenovaCare, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

RCAR NEWS

defenseworld.net

Feb 19

Contrasting Biofrontera (NASDAQ:BFRI) & RenovaCare (OTCMKTS:RCAR)

RenovaCare (OTCMKTS:RCAR - Get Free Report) and Biofrontera (NASDAQ: BFRI - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Insider and Institutional Ownership 10.1% of Biofrontera shares are owned

Company Profile

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

1996-05-30

Beta

-76.58

Websitewww.renovacareinc.com↗